Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Titan Biotech Ltd (NSE: TITANBIO), ISIN INE150C01029 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
TITANBIO last traded at ₹352.80 (+0.92%), with a 52-week range of ₹137.12 to ₹444.52 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 55.78%, FIIs 0.00%, DIIs 0.01%, mutual funds 0.00%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.